Health officials in England have detected a newly evolved mpox variant in a traveler who recently returned from Asia. Genome sequencing revealed that the virus is a recombinant strain — containing genetic material from both the more severe clade 1 and the less aggressive clade 2, the version behind the 2022 global outbreak.
The UK Health Security Agency announced that it is still assessing how significant this new form may be. While most mpox cases are mild, officials urge at-risk groups to get vaccinated. Experts note that viruses naturally evolve, and with both clades in circulation, a recombinant strain was not unexpected.
Mpox, formerly known as monkeypox, spreads through close physical contact, contaminated materials, or respiratory droplets. Symptoms may appear weeks after exposure and often include fever, headache, muscle pain and later a characteristic rash.
The discovery highlights the importance of continued monitoring, especially as mpox remains active worldwide. Nearly 48,000 cases and over 200 deaths have been confirmed globally this year. The UK continues its vaccination program for higher-risk individuals, and researchers will now watch closely to determine whether this new variant behaves differently in severity or transmission.
